The workshop took place on Saturday, November 12th in Houston. Visit http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=9394193 to learn more.

The workshop took place on Saturday, November 12th in Houston. Visit http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=9394193 to learn more.
Every October, Halliburton employees pledge money to charities of their choice through the company’s Giving Choices program, with the company providing a matching gift. Halo House is proud to announce that we have been selected to participate in this year’s Giving Choices program.
Each quarter, Twin Eagle selects a local non-profit organization to support, and encourages all employees to participate. Halo House Foundation was selected as their Q2 charitable partner, and the Twin Eagle team set a goal to sponsor up to one full year of housing for a family coming to Houston for leukemia, lymphoma, and myeloma […]
An anonymous donor believing so strongly in our organization and our mission decided to donate funds to lease two more apartments for two years! “So many more families coming to MD Anderson need help with housing” he said. Having the funds was only half the battle. We still needed a Halo House volunteer to manage […]
Thanks to Our Runners! Hundreds of runners and walkers made the 2nd annual Halo House 5K a big success! Many thanks to our loyal supporters, our generous sponsors, and all our runners and walkers who joined us on race day. Funds raised through the event will help Halo House provide a “home away from home” […]
On July 3rd Halo House Foundation celebrated the milestone of providing 10,000 days of housing to cancer patients! Our deepest gratitude to our dozens of dedicated and selfless volunteers, and to those who have provided financial support, for making this possible. Thank you! … It’s interesting to note that our guests have come from 19 […]
As if a cancer diagnosis is not distressing enough, an observational study presented at ASCO suggests that severe financial distress resulting from out-of-pocket costs associated with cancer treatment is associated with increased risk of death by 79%.